In this episode, Joe Moore interviews Brom Rector: podcaster and founder of Empath Ventures, a venture capital fund that invests in psychedelic medicine startups. Rector talks about which companies he sees succeeding, which companies are set up to fail, which he is investing in; and why the current crash (or lull) in psychedelic business is a good thing. He also discusses the theory of psychedelics damaging heart valves; the connection between Oprah, MDMA, and Mormons in UTAH; Xanax as a psychedelic security blanket; logical positivism; the DSM-5; Colorado Initiative 58; Mike Tyson; Compass Pathways; Christian Angermayer’s leaked memo; ibogaine; Dr. Zee and the next generation of Shulgins, and much, much more.

The post PT356 – Brom Rector – Investing in Psychedelics and The Rush to Improve on the Classics appeared first on Psychedelics Today.

Previous articleRevive Therapeutics Provides Update on the Psilocybin Clinical Study for Methamphetamine Use Disorder and Oral Psilocybin Thin Film Strip Program
Next articlePharmaTher Announces Late-Breaking Abstract Presentation of Positive Efficacy and Safety Data from Phase 1/2 Clinical Study of Ketamine in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease at the MDS International Congress of Parkinson’s Disease and Movement Disorders®